Medical treatments are always very costly. Most of us struggle throughout our life to earn money and after that as we retire several diseases are discovered inside our body. Medicines, numerous tests, surgeries, doctor visits etc etc. Well then all savings vanishes in thin air. The situation becomes more worse if we belong to the low-income group.
Social health insurance programs like Medicare and Medicaid are a little relief to the aged people and those seriously in need of aid. But a recent study by Penn State researchers proved that chronic treatments of diabetes receiving financial support from Medicare and Medicaid are costlier than than those who do not receive such payments.
It has been found that diabetes patients undergoing team-based care cannot save more in diagnostic costs under Medicare and Medicaid than other patients.
The Penn State researchers analyzed data between 1997 and 2005 from Medicaid and Medicare claims and payments one year before and after intervention for patients at CareSouth, a federally qualified community health center serving 10 clinics in and around Hartsville, South Carolina.
The analysis showed that the expenses were much greater in the clinic but the patients underwent significant improvement in systolic blood pressure, body mass index and hemoglobin A1C.
So even if longer-term savings do not materialize, Medicaid and Medicare patients in this study received greater value for their dollars in the CareSouth sites after the intervention.
The findings appeared in the recent issue of Diabetes Care.